Drug Supply Chain Management in COVID-19 Pandemic:Lessons from Iran and Preparation for Future

Authors

https://doi.org/10.22105/raise.vi.72

Abstract

The COVID-19 pandemic has caused unprecedented challenges to all nations worldwide. Among these challenges, a drug shortage can have adverse effects on the health of the world community. This paper in the evaluation of drug supply chain management during the COVID-19 pandemic focuses on the potential resources of drug shortage, initial preparation, and plans for eliminating probable shortages and improving Iran’s drug supply chain management The paper also makes some evidence-based suggestions to ensure the accessibility of drugs and improvement in drug supply chain management both during a pandemic and in the long run. Everyone involved in the supply chain needs to cooperate in a bid to achieve preparation and formulate transparent emergency plans to deal with the drug shortage caused by the COVID-19 pandemic. Therefore, it is essential to revise and improve supply chain management strategies, ensure transparent information, adopt active management, and maintain timely and comprehensive communication to sustain drug supply during a disease outbreak. In addition, raising public awareness of drug shortages, confronting misinformation, and providing timely responses to public opinion are among the factors that should be considered.

Keywords:

Supply chain management, Drug supply chain, Production, Pandemic, Drug shortage

References

  1. [1] Kuo, S., Ou, H. T., & Wang, C. J. (2021). Managing medication supply chains: Lessons learned from Taiwan during the COVID-19 pandemic and preparedness planning for the future. Journal of the american pharmacists association, 61(1), e12--e15. https://doi.org/10.1016/j.japh.2020.08.029
  2. [2] Jahangiri, S., Abolghasemian, M., Ghasemi, P., & Chobar, A. P. (2023). Simulation-based optimisation: analysis of the emergency department resources under COVID-19 conditions. International journal of industrial and systems engineering, 43(1), 1–19. https://doi.org/10.1504/IJISE.2023.128399
  3. [3] Horner, R. (2020). The world needs pharmaceuticals from China and India to beat coronavirus. The conversation, 25. https://www.telegraph.co.uk/global-health/science-and-disease/world-needs-pharmaceuticals-china-india-beat-coronavirus/
  4. [4] Olyaaeemanesh, A., Jaafaripooyan, E., Abdollahiasl, A., Davari, M., Mousavi, S. M., & Delpasand, M. (2021). Pharmaceutical subsidy policy in Iran: a qualitative stakeholder analysis. Health research policy and systems, 19(1), 150. https://doi.org/10.1186/s12961-021-00762-6
  5. [5] Cheraghali, A. M. (2013). Impacts of international sanctions on Iranian pharmaceutical market. DARU journal of pharmaceutical sciences, 21(1), 64. https://doi.org/10.1186/2008-2231-21-64
  6. [6] Kalinke, U., Barouch, D. H., Rizzi, R., Lagkadinou, E., Türeci, Ö., Pather, S., & Neels, P. (2022). Clinical development and approval of COVID-19 vaccines. Expert review of vaccines, 21(5), 609-619. https://doi.org/10.1080/14760584.2022.2042257
  7. [7] Kuriakose, S., Singh, K., Pau, A. K., Daar, E., Gandhi, R., Tebas, P., ... & Masur, H. (2021). Developing treatment guidelines during a pandemic health crisis: lessons learned from COVID-19. Annals of internal medicine, 174(8), 1151-1158. https://doi.org/10.7326/M21-1647
  8. [8] March, C. A., Flint, A., DeArment, D., Gilliland, A., Kelly, K., Rizzitano, E., … & Libman, I. M. (2020). Paediatric diabetes care during the COVID-19 pandemic: Lessons learned in scaling up telemedicine services. Endocrinology, diabetes & metabolism, 4(1), e00202. https://doi.org/10.1002/edm2.202
  9. [9] Herper, M. (2020). New Covid-19 study, despite flaws, adds to case against hydroxychloroquine. https://www.statnews.com/2020/07/16/new-covid-19-study-despite-flaws-adds-to-case-against-hydroxychloroquine/
  10. [10] Drug Shortages Task Force. (2021). Drug Shortages: Root Causes and Potential Solutions. https://www.fda.gov/media/131130/download
  11. [11] Jahangiri, S., Abolghasemian, M., Pourghader Chobar, A., Nadaffard, A., & Mottaghi, V. (2021). Ranking of key resources in the humanitarian supply chain in the emergency department of iranian hospital: a real case study in COVID-19 conditions. Journal of applied research on industrial engineering, 8(Special Issue), 1–10. https://doi.org/10.22105/jarie.2021.275255.1263

Downloads

Published

2025-06-20

Issue

Vol. 2 No. 3 (2025): Research Annals of Industrial and Systems Engineering

Section

Articles

How to Cite

Nobakht, Y. (2025). Drug Supply Chain Management in COVID-19 Pandemic:Lessons from Iran and Preparation for Future. Research Annals of Industrial and Systems Engineering, 2(3), 190-195. https://doi.org/10.22105/raise.vi.72